雷贝拉唑治疗幽门螺杆菌阳性消化性溃疡的临床效果评价

Evaluation Clinical Effect of Rabeprazole in Treatment of Helicobacter Pylori With Positive Peptic Ulcer

目的探讨雷贝拉唑治疗幽门螺杆菌阳性消化性溃疡的临床效果。方法收集100例幽门螺杆菌阳性消化性溃疡患者,随机分为观察组和对照组,每组50例。对照组使用常规奥美拉唑治疗,观察组实施雷贝拉唑的治疗。结果观察组的治疗有效率高于对照组,P<0.05,差异具有统计学意义。结论在对幽门螺杆菌阳性消化性溃疡患者实施药物治疗的过程中,通过使用雷贝拉唑进行治疗能够提升在临床治疗效果。

Objective To explore the rabeprazole clinical effect of treatment of helicobacter pylori positive peptic ulcer.Methods Selected 100 patients with helicobacter pylori positive peptic ulcer, randomly divided into observation group and control group, 50 cases in each group. The control group used conventional omeprazole treatment, the observation group of patients implement rabeprazole azole treatment. Results The treatment of patients with efficient observation group was higher than the control group,P〈0.05, had difference statistically significance.Conclusion In the implementation of drug treatment in patients with helicobacter pylori positive peptic ulcer, through the study of the treatment of patients with ray azole Bella can signiifcantly improve the clinical therapeutic effect.